87 related articles for article (PubMed ID: 17890503)
21. Fatty acids, IL6, and TNFalpha polymorphisms: an example of nutrigenetics in Crohn's disease.
Guerreiro CS; Ferreira P; Tavares L; Santos PM; Neves M; Brito M; Cravo M
Am J Gastroenterol; 2009 Sep; 104(9):2241-9. PubMed ID: 19550417
[TBL] [Abstract][Full Text] [Related]
22. Combined effects of saturated fat and cholesterol intakes on serum lipids: Tehran Lipid and Glucose Study.
Mirmiran P; Ramezankhani A; Azizi F
Nutrition; 2009 May; 25(5):526-31. PubMed ID: 19121920
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular risk factors in obese women and their first-degree relatives.
Saraç F; Ozgen AG; Yilmaz C; Tüzün M
Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
Szeto CC; Chow KM; Poon PY; Kwan BC; Li PK
Am J Nephrol; 2008; 28(5):715-22. PubMed ID: 18417957
[TBL] [Abstract][Full Text] [Related]
25. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
Pérez-Martínez P; Adarraga-Cansino MD; Fernández de la Puebla RA; Blanco-Molina A; Delgado-Lista J; Marín C; Ordovás JM; López-Miranda J; Pérez-Jiménez F
Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
[TBL] [Abstract][Full Text] [Related]
26. Relation of Trp64Arg polymorphism of beta3-adrenoreceptor gene with cardiovascular risk factors in presurgical morbidly obese patients.
de Luis DA; Aller R; Izaola O; Gonzalez-Sagrado M; Conde R
Arch Med Res; 2008 Nov; 39(8):791-5. PubMed ID: 18996293
[TBL] [Abstract][Full Text] [Related]
27. The quest for cardiovascular health in the genomic era: nutrigenetics and plasma lipoproteins.
Ordovas JM
Proc Nutr Soc; 2004 Feb; 63(1):145-52. PubMed ID: 15070444
[TBL] [Abstract][Full Text] [Related]
28. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults.
Ghandehari H; Le V; Kamal-Bahl S; Bassin SL; Wong ND
Int J Obes (Lond); 2009 Feb; 33(2):239-48. PubMed ID: 19050677
[TBL] [Abstract][Full Text] [Related]
29. Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia.
Jansen AC; van Aalst-Cohen ES; Tanck MW; Cheng S; Fontecha MR; Li J; Defesche JC; Kastelein JJ
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1475-81. PubMed ID: 15879303
[TBL] [Abstract][Full Text] [Related]
30. Waist circumference and visceral fat in CKD: a cross-sectional study.
Sanches FM; Avesani CM; Kamimura MA; Lemos MM; Axelsson J; Vasselai P; Draibe SA; Cuppari L
Am J Kidney Dis; 2008 Jul; 52(1):66-73. PubMed ID: 18440683
[TBL] [Abstract][Full Text] [Related]
31. Blood pressure and cardiovascular risk profiles of Africans who migrate to a Western country.
Dominguez LJ; Galioto A; Pineo A; Ferlisi A; Vernuccio L; Belvedere M; Costanza G; Putignano E; Barbagallo M
Ethn Dis; 2008; 18(4):512-8. PubMed ID: 19157258
[TBL] [Abstract][Full Text] [Related]
32. Low fasting triglycerides: hallmark of the healthy large hip?
Ruige JB; Van Gaal LF
Obesity (Silver Spring); 2009 Aug; 17(8):1621-6. PubMed ID: 19247283
[TBL] [Abstract][Full Text] [Related]
33. Personalized nutrition for the prevention of cardiovascular disease: a future perspective.
Lovegrove JA; Gitau R
J Hum Nutr Diet; 2008 Aug; 21(4):306-16. PubMed ID: 18721398
[TBL] [Abstract][Full Text] [Related]
34. Trans fat intake lowers total cholesterol and high-density lipoprotein cholesterol levels without changing insulin sensitivity index in Wistar rats.
Huang Z; Wang B; Pace RD; Yoon S
Nutr Res; 2009 Mar; 29(3):206-12. PubMed ID: 19358935
[TBL] [Abstract][Full Text] [Related]
35. Type 2 diabetes mellitus and other cardiovascular risk factors are no more common during menopause: longitudinal study.
Soriguer F; Morcillo S; Hernando V; Valdés S; Ruiz de Adana MS; Olveira G; Fuentes EG; González I; Tapia MJ; Esteva I; Rojo-Martínez G
Menopause; 2009; 16(4):817-21. PubMed ID: 19387417
[TBL] [Abstract][Full Text] [Related]
36. Interaction between PPARG Pro12Ala and ADIPOQ G276T concerning cholesterol levels in childhood obesity.
Johansson LE; Danielsson P; Norgren S; Marcus C; Ridderstråle M
Int J Pediatr Obes; 2009; 4(2):119-25. PubMed ID: 18645733
[TBL] [Abstract][Full Text] [Related]
37. The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Québec Family Study.
Robitaille J; Després JP; Pérusse L; Vohl MC
Clin Genet; 2003 Feb; 63(2):109-16. PubMed ID: 12630956
[TBL] [Abstract][Full Text] [Related]
38. Dietary energy density is associated with body mass index and waist circumference, but not with other metabolic risk factors, in free-living young Japanese women.
Murakami K; Sasaki S; Takahashi Y; Uenishi K;
Nutrition; 2007; 23(11-12):798-806. PubMed ID: 17936194
[TBL] [Abstract][Full Text] [Related]
39. Nutrigenomics in cardiovascular disease: implications for the future.
Engler MB
Prog Cardiovasc Nurs; 2009 Dec; 24(4):190-5. PubMed ID: 20002344
[TBL] [Abstract][Full Text] [Related]
40. Nutrigenetics, plasma lipids, and cardiovascular risk.
Ordovas JM
J Am Diet Assoc; 2006 Jul; 106(7):1074-81; quiz 1083. PubMed ID: 16815124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
